Twitter

It’s almost the end of #PrideMonth. Fear not, Alex Gardiner has written a follow-up to his first article which shar… https://t.co/o7aaUqLVS3

RT: Boutique IP firm @EIP has expanded its partnership, this time through the hire of an electronics-specialist patent… https://t.co/VygaYtfvPG

It’s great to see we have been ranked by @PatentLawyerMag as one of their 10 most well-respected law firms in the U… https://t.co/XbiHBIqseh

RT: CONGRATULATIONS to @EIP for achieving the status of Award Winning Law Firm in the United Kingdom in The Patent Lawy… https://t.co/UglkXukjdx

Congratulations to Florian Schmidt-Bogatzky for being recognised in The Best Lawyers – Germany! Florian has been li… https://t.co/tDLp2IcUD0

Congratulations to Florian Schmidt-Bogatzky for being recognised in The Best Lawyers – Germany! Florian has been li… https://t.co/00s8qsQXNN

EIP Talks turned 1 this month! Check out all the episodes we’ve released over the past year and be sure to subscrib… https://t.co/gdld2A369g

Join us as our next #Trainee #Solicitor! We are keen to hear from #law graduates & #STEM graduates who have a keen… https://t.co/8XulNBc2j8

RT: Gilenya injunction bid: big pharma takeaways. The England and Wales Patent Court affirmed its power to grant injunc… https://t.co/aoYLUAKSv1

Novartis was refused a preliminary injunction to keep Teva and four other generics off the market for its MS treatm… https://t.co/bz98l34HDS

Novartis was refused a preliminary injunction to keep Teva and four other generics off the market for its MS treatm… https://t.co/mvQ3AxromU

Novartis was refused a preliminary injection to keep Teva and four other generics off the market for its MS treatme… https://t.co/jXM9SmuEGQ

The 60th edition of @PatentLawyerMag is now out. It features an article from Andrew Sharples about FRAND and the su… https://t.co/wDX6vSRZuJ

Congratulations to Mark Lubbock who has been recognised by @IP_STARS as an IP Star for Transactions! Read more:… https://t.co/4i1sVcHHIS

Check out our new Unified Patent Court (UPC) series of short explainers about the system, whether you want to use t… https://t.co/SYcBWYTUNi

Read Alex Gardiner’s latest article where he calls for more to be done around the globe to support LGBTQ+ rights in… https://t.co/57Yf1iSvjH

We had a great time at #MOVE2022 last week! Missed us at our stand? Check out our mobility insights hub where Matt… https://t.co/VOUiXBV5dB

RT: Solving the PCT Priority problem. The ‘joint applicants’ approach to PCT applications could offer a solution to iss… https://t.co/dIkYT1ipT7

RT: Really looking forward to this event. Just one month to go! https://t.co/sLd9X5rcMt

We are delighted @EIP_Elements will be the keynote speaker at the ‘LGBTIQ+ & Friends – Legal & IP’ event in Düsseld… https://t.co/lq7Lr5svAc

It’s great to see we have once again been recognised by the @FT as one of Europe’s Leading Patent Law Firms! Highly… https://t.co/laZ3VF0ER0

We are delighted to have won @ManagingIP’s ‘Patent Contentious – Firm of the Year (EMEA)’ award last night! Learn m… https://t.co/xfJ4gbxKb1

We are very much looking forward to attending @ManagingIP’s 17th annual award ceremony tonight! Good luck to everyo… https://t.co/j1JZrbsbGk

We will be at #MOVE2022 over the next two days! Drop by our stand, meet the team and play our patent game. https://t.co/hzCb5aI2G3

We had a fantastic time at the 20th annual Rocky Mountain IP & Technology Law Institute earlier this month! Thank y… https://t.co/sCh2CP90q4

Want to know more about the Unified Patent Court (UPC)? We’ve published a series of short explainers about the syst… https://t.co/854OxRcH5C

RT: Neurim, Flynn discover that time is not on their side. A case at the English High Court reinforced the need for int… https://t.co/eW6dmrFLjt

RT: This morning we have another great #PrideMonth post we wanted to share. This post by @EIP Associate Alex Gardiner d… https://t.co/OVpqmyWEjo

Why was Novartis refused a preliminary injunction to keep Teva and four other generics off the market for its MS tr… https://t.co/CrNAoyQhob

RT: A thought-provoking article from Alex on #pridemonth2022 - rights and acceptance for LGBTQ+ people are going backwa… https://t.co/tiy6eOUujS

Happy #PrideMonth! Check out this article by Alex Gardiner on the success of Pride Month over the years, but is it… https://t.co/WJhwzsFq8y

Congratulations to Heather McCann for being recognised by @IP_STARS as a leading practitioner! https://t.co/vpE3g83FZE

Neurim and Flynn denied interim injunction over insomnia drug again. Read Lydia Birch's latest update on Neurim and… https://t.co/rcaulnputd

RT: Neurim, Flynn discover time is not on their side. A case at the English High Court reinforced the need for interim… https://t.co/DZIdAcYSCW

We’re gearing up for #MOVE2022! Ahead of the event, Rebecca Oliver has produced an article on mobility as a service… https://t.co/DXFrCbjx5C

We are proud sponsors of #IPBCGlobal 2022! Christof Höhne, Florian Schmidt-Bogatzky, Kathleen Fox Murphy and James… https://t.co/xvFHerzAW6

Congratulations to Rick Gordon-Brown, Paula Flutter and Carl Bryers on being recognised as a 2022 @WorldIPReview Le… https://t.co/24DKRa0y6z

It is great to see that both Gary Moss and Christof Höhne have been shortlisted for ‘Practitioner of the Year’ by… https://t.co/in5b0HIkv8

Read Lydia Birch’s latest update in the Neurim and Flynn dispute where Mr Justice Mellor refused the Claimants’ app… https://t.co/H1W6MmUTJL

Read India Badini’s overview of the claim for infringement of a UK & EU registered trademark brought in IPEC by Lue… https://t.co/zGZiYstpuI